EUCTR2007-005531-28-SE进行中（未招募）不适用
rsodeoxycholic Acid in Morbidly Obese Patients Before Bariatric Surgery - UrsoObese
Hanns-Ulrich Marschall0 个研究点开始时间: 2008年2月15日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Morbidly obese (BMI >35 kg/m2) patients of both gender scheduled for bariatric surgery.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years)
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years)
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Any condition that does not allow bariatric surgery, i.e. major cardiovascular, liver or kidney disease, pregnancy, drug abuse.
- •Insulin-dependent or independent diabetes mellitus.
研究者
相似试验
招募中
不适用
The Impact of Weight Loss on the Metabolic SyndromeMetabolic SyndromeMetabolic and Endocrine - Metabolic disordersObesityACTRN12610000049077Monash University - Centre for Obesity Research and Education200
进行中（未招募）
1 期
A trial of a new drug, obeticholic acid, in patients with diarrhoea caused by bile acidsBile acid diarrhoea (also known as bile acid malabsorption)EUCTR2011-003777-28-GBImperial College London and Imperial College Healthcare NHS Trust35
进行中（未招募）
不适用
Deoxycholic acid as treatment of abdominal fatACTRN12618001775202Deshan Sebaratnam1
进行中（未招募）
不适用
se of Equipment and Resources of Physiotherapy in Morbidly Obese Patients Undergoing Stomach Reduction SurgeryPulmonary atelectasis, obesityC08.381.730C18.654.726.500RBR-23gvd4niversidade Metodista de Piracicaba - UNIMEP
已完成
不适用
Plasma anti Xa-levels in obese patients undergoing bariatric surgery and receiving low molecular weight heparins for thromboprophylaxis.venous thromboembolismNL-OMON37877Slotervaartziekenhuis45